Different P105 promoter activities among natural variants of human papillomavirus type 18

被引:37
作者
Sichero, L
Franco, EL
Villa, LL
机构
[1] Ludwig Inst Canc Res, Dept Virol, BR-01509010 Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil
[3] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada
[4] McGill Univ, Dept Oncol, Montreal, PQ, Canada
关键词
D O I
10.1086/427825
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Association between non-European variants of human papillomavirus (HPV) type 16 (HPV-16) and HPV-18 and cervical lesions has been suggested. To compare the P105 promoter activity among 6 HPV-18 variants, their complete long control regions (LCRs), as well as that of HeLa cells, were cloned upstream of the luciferase gene and transiently transfected in C33 cells. Whereas the B18-2 European variant showed the lowest promoter activity, the Asian-Amerindian variant, B183, had the highest activity. All variants tested were more active than the P97 HPV-16 prototype promoter. Differences in the LCR that impact P105 promoter activity could be responsible for the observed variability in oncogenic potential.
引用
收藏
页码:739 / 742
页数:4
相关论文
共 16 条
  • [1] Bernard HU, 2002, ANTIVIR THER, V7, P219
  • [2] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [3] Burk RD, 2003, CANCER RES, V63, P7215
  • [4] Franco E, 1999, Rev Panam Salud Publica, V6, P223, DOI 10.1590/S1020-49891999000900001
  • [5] GENETIC-CHARACTERIZATION OF THE HUMAN PAPILLOMAVIRUS (HPV) 18-E2 GENE IN CLINICAL SPECIMENS SUGGESTS THE PRESENCE OF A SUBTYPE WITH DECREASED ONCOGENIC POTENTIAL
    HECHT, JL
    KADISH, AS
    JIANG, G
    BURK, RD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (03) : 369 - 376
  • [6] Host and viral genetics and risk of cervical cancer: a review
    Hildesheim, A
    Wang, SS
    [J]. VIRUS RESEARCH, 2002, 89 (02) : 229 - 240
  • [7] Kämmer C, 2000, J GEN VIROL, V81, P1975, DOI 10.1099/0022-1317-81-8-1975
  • [8] Association between human papillomavirus type 18 variants and histopathology of cervical cancer
    Lizano, M
    Berumen, J
    Guido, MC
    Casas, L
    GarciaCarranca, A
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (16) : 1227 - 1231
  • [9] EVOLUTION OF HUMAN PAPILLOMAVIRUS TYPE-18 - AN ANCIENT PHYLOGENETIC ROOT IN AFRICA AND INTRATYPE DIVERSITY REFLECT COEVOLUTION WITH HUMAN ETHNIC-GROUPS
    ONG, CK
    CHAN, SY
    CAMPO, MS
    FUJINAGA, K
    MAVROMARANAZOS, P
    LABROPOULOU, V
    PFISTER, H
    TAY, SK
    TERMEULEN, J
    VILLA, LL
    BERNARD, HU
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (11) : 6424 - 6431
  • [10] Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma
    Pirog, EC
    Kleter, B
    Olgac, S
    Bobkiewicz, P
    Lindeman, J
    Quint, WGV
    Richart, RM
    Isacson, C
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) : 1055 - 1062